Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1984

Schlagwörter:	Multiple Sclerosis Linoleic Acid Oleic Acid Relapse Rate Multiple Sclerosis Patient

Anmerkung:	© Adis International Ltd 1984

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 464(1984), 1 vom: Nov., Seite 13-13
Übergeordnetes Werk:	volume:464 ; year:1984 ; number:1 ; month:11 ; pages:13-13

Links:	Volltext

DOI / URN:	10.1007/BF03316209

Katalog-ID:	SPR035876530

Internformat


LEADER	01000caa a22002652 4500
001	SPR035876530
003	DE-627
005	20230519163715.0
007	cr uuu---uuuuu
008	201007s1984 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/BF03316209 \|2 doi
035			\|a (DE-627)SPR035876530
035			\|a (SPR)BF03316209-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients
264		1	\|c 1984
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1984
650		4	\|a Multiple Sclerosis \|7 (dpeaa)DE-He213
650		4	\|a Linoleic Acid \|7 (dpeaa)DE-He213
650		4	\|a Oleic Acid \|7 (dpeaa)DE-He213
650		4	\|a Relapse Rate \|7 (dpeaa)DE-He213
650		4	\|a Multiple Sclerosis Patient \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 464(1984), 1 vom: Nov., Seite 13-13 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:464 \|g year:1984 \|g number:1 \|g month:11 \|g pages:13-13
856	4	0	\|u https://dx.doi.org/10.1007/BF03316209 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 464 \|j 1984 \|e 1 \|c 11 \|h 13-13

Indexfelder

matchkey_str	article:22306056:1984----::otirgrlnliaifrutpec
hierarchy_sort_str	1984
publishDate	1984
allfields	10.1007/BF03316209 doi (DE-627)SPR035876530 (SPR)BF03316209-e DE-627 ger DE-627 rakwb eng Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients 1984 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1984 Multiple Sclerosis (dpeaa)DE-He213 Linoleic Acid (dpeaa)DE-He213 Oleic Acid (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Multiple Sclerosis Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 464(1984), 1 vom: Nov., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:464 year:1984 number:1 month:11 pages:13-13 https://dx.doi.org/10.1007/BF03316209 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 464 1984 1 11 13-13
spelling	10.1007/BF03316209 doi (DE-627)SPR035876530 (SPR)BF03316209-e DE-627 ger DE-627 rakwb eng Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients 1984 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1984 Multiple Sclerosis (dpeaa)DE-He213 Linoleic Acid (dpeaa)DE-He213 Oleic Acid (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Multiple Sclerosis Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 464(1984), 1 vom: Nov., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:464 year:1984 number:1 month:11 pages:13-13 https://dx.doi.org/10.1007/BF03316209 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 464 1984 1 11 13-13
allfields_unstemmed	10.1007/BF03316209 doi (DE-627)SPR035876530 (SPR)BF03316209-e DE-627 ger DE-627 rakwb eng Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients 1984 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1984 Multiple Sclerosis (dpeaa)DE-He213 Linoleic Acid (dpeaa)DE-He213 Oleic Acid (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Multiple Sclerosis Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 464(1984), 1 vom: Nov., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:464 year:1984 number:1 month:11 pages:13-13 https://dx.doi.org/10.1007/BF03316209 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 464 1984 1 11 13-13
allfieldsGer	10.1007/BF03316209 doi (DE-627)SPR035876530 (SPR)BF03316209-e DE-627 ger DE-627 rakwb eng Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients 1984 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1984 Multiple Sclerosis (dpeaa)DE-He213 Linoleic Acid (dpeaa)DE-He213 Oleic Acid (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Multiple Sclerosis Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 464(1984), 1 vom: Nov., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:464 year:1984 number:1 month:11 pages:13-13 https://dx.doi.org/10.1007/BF03316209 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 464 1984 1 11 13-13
allfieldsSound	10.1007/BF03316209 doi (DE-627)SPR035876530 (SPR)BF03316209-e DE-627 ger DE-627 rakwb eng Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients 1984 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1984 Multiple Sclerosis (dpeaa)DE-He213 Linoleic Acid (dpeaa)DE-He213 Oleic Acid (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Multiple Sclerosis Patient (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 464(1984), 1 vom: Nov., Seite 13-13 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:464 year:1984 number:1 month:11 pages:13-13 https://dx.doi.org/10.1007/BF03316209 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 464 1984 1 11 13-13
language	English
source	Enthalten in Inpharma weekly 464(1984), 1 vom: Nov., Seite 13-13 volume:464 year:1984 number:1 month:11 pages:13-13
sourceStr	Enthalten in Inpharma weekly 464(1984), 1 vom: Nov., Seite 13-13 volume:464 year:1984 number:1 month:11 pages:13-13
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Multiple Sclerosis Linoleic Acid Oleic Acid Relapse Rate Multiple Sclerosis Patient
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1984-11-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035876530
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035876530</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519163715.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1984 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03316209</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035876530</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03316209-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1984</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1984</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple Sclerosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Linoleic Acid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oleic Acid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Relapse Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple Sclerosis Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">464(1984), 1 vom: Nov., Seite 13-13</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:464</subfield><subfield code="g">year:1984</subfield><subfield code="g">number:1</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:13-13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03316209</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">464</subfield><subfield code="j">1984</subfield><subfield code="e">1</subfield><subfield code="c">11</subfield><subfield code="h">13-13</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients Multiple Sclerosis (dpeaa)DE-He213 Linoleic Acid (dpeaa)DE-He213 Oleic Acid (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Multiple Sclerosis Patient (dpeaa)DE-He213
topic	misc Multiple Sclerosis misc Linoleic Acid misc Oleic Acid misc Relapse Rate misc Multiple Sclerosis Patient
spellingShingle	misc Multiple Sclerosis misc Linoleic Acid misc Oleic Acid misc Relapse Rate misc Multiple Sclerosis Patient Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients
topic_unstemmed	misc Multiple Sclerosis misc Linoleic Acid misc Oleic Acid misc Relapse Rate misc Multiple Sclerosis Patient
topic_browse	misc Multiple Sclerosis misc Linoleic Acid misc Oleic Acid misc Relapse Rate misc Multiple Sclerosis Patient
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients
ctrlnum	(DE-627)SPR035876530 (SPR)BF03316209-e
title_full	Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1984
contenttype_str_mv	txt
container_start_page	13
container_volume	464
format_se	Elektronische Aufsätze
doi_str_mv	10.1007/BF03316209
title_sort	don’t disregard linoleic acid for multiple sclerosis patients
title_auth	Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients
abstract	© Adis International Ltd 1984
abstractGer	© Adis International Ltd 1984
abstract_unstemmed	© Adis International Ltd 1984
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients
url	https://dx.doi.org/10.1007/BF03316209
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1007/BF03316209
up_date	2024-07-03T16:01:48.430Z
_version_	1803574321802641408
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035876530</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519163715.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1984 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03316209</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035876530</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03316209-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1984</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1984</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple Sclerosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Linoleic Acid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oleic Acid</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Relapse Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multiple Sclerosis Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">464(1984), 1 vom: Nov., Seite 13-13</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:464</subfield><subfield code="g">year:1984</subfield><subfield code="g">number:1</subfield><subfield code="g">month:11</subfield><subfield code="g">pages:13-13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03316209</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">464</subfield><subfield code="j">1984</subfield><subfield code="e">1</subfield><subfield code="c">11</subfield><subfield code="h">13-13</subfield></datafield></record></collection>
score	7.398081

Nicht das Richtige dabei?

Schreiben Sie uns!

Don’t Disregard Linoleic Acid for Multiple Sclerosis Patients

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?